Dublin, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The "Biobanks Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2017-2027 Segmented By Type, By Sample Type, By Application, By End User, By Region" report has been added to ResearchAndMarkets.com's offering. The Global Biobanks Market stood at USD40.70 billion in 2021 and is expected to grow at an impressive rate of 8.22% during the forecast period. This can be ascribed to the growing investments and research & development in advanced therapies such as cancer genomic studies, personalized medicine, among others. Biobanks play a pivotal role in disease diagnosis and development of a treatment or drug. The COVID-19 pandemic crisis has significantly increased the demand for biobanks worldwide. During the pandemic crisis various new specialized biobanks, focusing on COVID-19 were developed for research & development activities. For instance, in July 2021, Tulane University announced a new COVID-19 biobank containing blood & cell samples from survivors. Regenerative Medicine Applications for Biobanking Market will drive the Market

Biobanks Market contributes to the advancement of biomedical and translational research by collecting and preserving biological samples such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this information is then used for diagnosis, prognosis, and drug response prediction.

The increase in the number of research activities in this area is a major market driver. The availability of government financing for regenerative medicine, stem cell treatments, and cell and gene therapy are fueling this segment's research. Aside from that, the growing trend of cord blood banking will help this market segment develop. Future possibilities are predicted to include breakthroughs in orthopaedic therapies utilising stem cells. Stakeholders Shifting Focus from Sample-driven to Data-driven Strategies

Precision medicine research is gaining traction as a result of the digital revolution. Precision medicine research and clinical data are also inextricably linked. Although there are times when there are modest connections between the two variables. Because the availability of data on well-characterized and high-quality samples is of relevance to healthcare organizations, this works as a profitable opportunity for stakeholders in the biobanking market. Artificial intelligence (AI) and big data analytics are being introduced into the biobanking landscape in order to develop strong correlations between precision medicine research and clinical data. This has aided faster research, which has had a positive impact on the delivery of new pharmaceuticals in the healthcare industry. As a result, there is a growing demand in the biobanking industry for increased informatics capabilities. Demand for Temperature Control Systems to Gain Strength in Biobanks Market

Biobanks are in high demand to preserve a variety of biospecimen, from blood to tissues, cells, and nucleic acids, due to the growing trend of personalized treatments to reduce chronic disease-related mortality rates. As major manufacturers are focusing their efforts on the release of freezers and refrigerators, cryogenic storage systems, and other equipment for the storage of biobank samples, the market is expected to place a greater emphasis on temperature control systems, boosting global demand for Biobanks. The equipment segment is being driven by an increase in the number of Biobanks in several countries, as well as a desire for sophisticated biobanking equipment. Market Segmentation

The Global Biobanks Market is segmented based on Type, Sample Type, Application, End-User, Region, and by Company. Based on Type, the market is further fragmented into Disease Oriented Biobanks, Population Based Biobanks, Tissue Biobanks and Others. Based on Sample Type, the market is segmented into Blood Products, Biological fluids, Nucleic Acid, Cell Lines and Others.

Also, segmentation of the market based on the Application is done into Therapeutics, Drug Discovery, Clinical Diagnostic and Clinical Research. Based on End-User, the market is further fragmented into Academic & Research Institutes, Pharma & Biotech Companies, Hospitals & Clinics and Others. The market analysis also studies the regional segmentation divided among North American region, Asia-Pacific region, European region, Middle East & African region, South American region.

The North America dominated the market in 2021 and is projected to maintain its dominance during the forecast period. United States market for biobanks was the largest and stood at USD9.03 billion in 2021. This can be ascribed to the large number of biobanks establishments in the country. Company Profiles

Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Avantor, Inc., Thermo Fisher Scientific, Inc, Tecan Trading AG, QIAGEN N.V. Hamilton Company, ProMedDx, LLC, ISENET Biobanking S.r.l., are among the major market players in the Global Biobanks Market.

Key Topics Covered: 1. Product Overview 2. Research Methodology 3. Executive Summary 4. Impact of COVID-19 on Global Biobanks Market 5. Voice of Customer 5.1. Factors Contributing to Demand for Biobanks 5.2. Source of Information 5.3. Preference for Biobanks, By Type 5.4. Unmet Needs/Challenges 6. Global Biobanks Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Type (Disease Oriented Biobanks, Population Based Biobanks, Tissue Biobanks, Others) 6.2.2. By Sample Type (Blood Products, Biological fluids, Nucleic Acid, Cell Lines, Others 6.2.3. By Application (Therapeutics, Drug Discovery, Clinical Diagnostics, Clinical Research 6.2.4. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinics, Others) 6.2.5. By Company (2021) 6.2.6. By Region 6.3. Product Market Map 7. North America Biobanks Market Outlook 8. Europe Biobanks Market Outlook 9. Asia-Pacific Biobanks Market Outlook 10. South America Biobanks Market Outlook 11. Middle East and Africa Biobanks Market Outlook 12. Market Dynamics 12.1. Drivers 12.2. Challenges 13. Market Trends & Developments 14. Competitive Landscape 14.1. Danaher Corporation 14.2. Merck KGaA 14.3. Becton, Dickinson, and Company 14.4. Avantor, Inc. 14.5. Thermo Fisher Scientific, Inc 14.6. Tecan Trading AG 14.7. QIAGEN N.V. 14.8. Hamilton Company 14.9. ProMedDx, LLC 14.10. ISENET Biobanking S.r.l 15. Strategic Recommendations For more information about this report visit https://www.researchandmarkets.com/r/hox6y9

KEY WORDS “I think we’re giving Powell too much praise. … The last two years are one of the biggest policy mistakes in the 110-year history of the Fed by staying so easy when everything was booming.

Dividends can be used to create passive income in an investment portfolio or grow wealth over the long term through reinvestment. Knowing how to live off dividends may be central to your retirement planning strategy if you want to avoid … Continue reading → The post How Much Do You Need to Live Off Dividends? appeared first on SmartAsset Blog.

Today, with the stock market in meltdown mode, it’s natural to look back at other times of financial woe. The market environment in the 1970s can be particularly instructive.

These highly innovative and differentiated companies are ripe for the picking following a peak plunge of 34% in the Nasdaq Composite.

Goldman finally decided to stop fighting the Fed and no longer sees the index finishing the year at 4300.

Warren Buffett’s long-term investment strategy has proven to be successful through virtually all market conditions over the past several decades – recession, high inflation and deflation. If there’s one thing that’s made Buffett one of the most successful investors in history, it’s his commitment to his strategy. A countless number of new investment techniques and algorithms have come and gone over the years, but Buffett has maintained his relatively simple strategy of picking solid companies an

Once just a gaming chip company, it has successfully repurposed its technology to the latest technological advancements, including artificial intelligence and the metaverse. Investors will struggle to replicate such huge returns, but semiconductor stock investors who missed out could perhaps see similar outsized gains by buying stock in one of Nvidia's main rivals, Advanced Micro Devices (NASDAQ: AMD). Admittedly, AMD may seem like a strange choice here since it has slightly exceeded Nvidia's returns since the beginning of 2015, rising by 2,700%.

The shipping company has developed a reputation as one of the best dividend stocks around

Trending social-media hashtags aside, the U.S. stock market hasn't crashed --- but a volatile bear market is making for queasy investors.

AT&T has been crushed this year, down more than 40% from its high. But now the stock nears a key area on the charts with a 7% dividend yield.

Market forces rained on the parade of Novavax, Inc. ( NASDAQ:NVAX ) shareholders today, when the analysts downgraded...

Yahoo Finance Live anchor Seana Smith highlights stocks moving in after-hours trading, including Ford, FedEx, and Moderna.

AT&T Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $T performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.Check out the ticker page here.

AT&T (NYSE: T) and IBM (NYSE: IBM) both underwent dramatic transformations over the past year. AT&T divested DirecTV, merged WarnerMedia with Discovery to create Warner Bros. Discovery (NASDAQ: WBD) , and sold many of its non-core assets to prioritize the growth of its core telecom business.

The hedge fund legend has spoken. Pay attention.

Institutional ownership of single-family homes has been a controversial topic over the past year. Investors purchased a record-high number of rental properties while many would-be homeowners were priced out of the market. The largest owner of this asset class in the U.S. is Invitation Homes Inc. (NYSE: INVH), a real estate investment trust (REIT) with a portfolio of about 83,000 single-family rental homes as of the end of the first quarter this year. The company’s portfolio is mainly made up of

(Bloomberg) -- Russia’s wheat harvest could reach a historic 100 million tons, according to consultant SovEcon, with the commodity piling up at home as the nation struggles to export large volumes.Most Read from BloombergBank of England Says Paper Banknotes Only Good for One More WeekJapan to Restore Visa-Free Travel From Oct. 11 as Covid Pandemic Recedes South Korea President Caught on Hot Mic Insulting US CongressUnless Rents Rise, Housing Is Set Up for an Epic CrashA Great Copper Squeeze Is C

There are two important things everyday investors need to remember during times like these. Shares of SoFi Technologies (NASDAQ: SOFI) have lost 64.6% of their value this year in response to rising interest rates and fear of a recession.

Yahoo Finance Editor-in-Chief Andy Serwer explains what investors can learn from historical bear markets. 

Sales have taken hits due to changes in crypto mining, U.S. legislation, and broad shifts in consumer spending.